- Investing Ideas
- /
- U.S. Biotech Stocks
U.S. Biotech Stocks
Results
517
Even though biotechnology stocks can be very risky, they can also offer some of the biggest rewards with huge profits on offer when you find the right one. The companies below all have reasonable balance sheets and value, giving the best chance of finding a gem.
517 companies
Scorpius Holdings
Market Cap: US$694.7k
Through its subsidiary Scorpius BioManufacturing, operates as an integrated contract development and manufacturing organization.
SCPX
US$0.14
7D
4.6%
1Y
-99.6%
TNF Pharmaceuticals
Market Cap: US$692.9k
A clinical stage pharmaceutical company, focuses on developing two novel therapeutic platforms that treat the causes of disease rather than addressing the symptoms.
TNFA
US$0.26
7D
-36.3%
1Y
-89.7%
Telesis Bio
Market Cap: US$657.1k
A synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide.
TBIO
US$1.10
7D
292.7%
1Y
-86.0%
Biora Therapeutics
Market Cap: US$552.9k
A clinical-stage biotechnology company, engages in developing oral biotherapeutics in the United States.
BIOR.Q
US$0.12
7D
-4.5%
1Y
-98.2%
Onconetix
Market Cap: US$527.5k
A biotechnology company, focuses on the research, development, and commercialization of solutions for men’s health and oncology.
ONCO
US$0.058
7D
-23.6%
1Y
-99.1%
Altamira Therapeutics
Market Cap: US$419.1k
Operates as a preclinical-stage biopharmaceutical company in Switzerland and Australia.
CYTO.F
US$0.06
7D
-14.1%
1Y
-96.7%
TC Biopharm (Holdings)
Market Cap: US$84.1k
A clinical-stage biopharmaceutical company, focuses on the development of immunotherapy products based on its allogeneic gamma delta T cell platform.
TCBP.Y
US$0.30
7D
0%
1Y
-99.9%
Cannonau
Market Cap: US$48.4k
Provides cannabidiol based products.
CNNC
US$0.0002
7D
-33.3%
1Y
-98.3%
Ampio Pharmaceuticals
Market Cap: US$681.0
A biopharmaceutical company, engages in the development of therapies for the treatment of osteoarthritis of the knee (OAK) in the United States.
AMPE
US$0.0006
7D
0%
1Y
-99.9%
Molecular Templates
Market Cap: US$658.0
A clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases in the United States.
MTEM
US$0.0001
7D
0%
1Y
-100.0%
Clever Leaves Holdings
Market Cap: US$350.0
Operates in the botanical cannabinoid and nutraceutical industries.
CLVR
US$0.0002
7D
0%
1Y
-100.0%
NexImmune
Market Cap: US$139.0
A clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases in the United States.
NEXI
US$0.0001
7D
0%
1Y
-100.0%
DermTech
Market Cap: US$35.0
A molecular diagnostic company, engages in the development and marketing of novel non-invasive genomics tests to aid in the diagnosis and management of melanoma in the United States.
DMTK.Q
US$0.000001
7D
-90.0%
1Y
-100.0%